Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bococizumab in hypercholesterolemia
NCT01350141Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2011
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of bococizumab in hypercholesterolemia, sponsored by Pfizer. Started Jun 2011; status: completed.
02
Drugs
bococizumab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT01350141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01350141.